• Tue news: Pfizer explores sale of hospital drugs unit. FDA declines full approval of Ocaliva. AZ better than expected Q3 results. Pfizer, Lilly telehealth platforms draw scrutiny. 23andMe cutting lays off 40%. See more on our front page

Novartis funnels $300M into early biologic drug manufacturing

Quote
cafead

cafead

Administrator
Staff member
  • cafead   Sep 12, 2022 at 11:42: PM
via Novartis will spend $300 million to bolster its development and production capabilities for biologic medicines, which make up an increasing share of its drug pipeline.

article source
 




Top Bottom
Back
Quote